133 related articles for article (PubMed ID: 19035285)
1. Antitumor effects of desmopressin in combination with chemotherapeutic agents in a mouse model of breast cancer.
Ripoll GV; Giron S; Krzymuski MJ; Hermo GA; Gomez DE; Alonso DF
Anticancer Res; 2008; 28(5A):2607-11. PubMed ID: 19035285
[TBL] [Abstract][Full Text] [Related]
2. Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer.
Ripoll GV; Garona J; Hermo GA; Gomez DE; Alonso DF
Anticancer Res; 2010 Dec; 30(12):5049-54. PubMed ID: 21187489
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation.
Giron S; Tejera AM; Ripoll GV; Gomez DE; Alonso DF
J Surg Oncol; 2002 Sep; 81(1):38-44. PubMed ID: 12210026
[TBL] [Abstract][Full Text] [Related]
4. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.
Ripoll GV; Farina HG; Yoshiji H; Gomez DE; Alonso DF
In Vivo; 2006; 20(6B):881-5. PubMed ID: 17203783
[TBL] [Abstract][Full Text] [Related]
6. Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice.
Garona J; Pifano M; Scursoni AM; Gomez DE; Alonso DF; Ripoll GV
Anticancer Res; 2014 Sep; 34(9):4761-5. PubMed ID: 25202055
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
8. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
10. Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.
Garona J; Pifano M; Pastrian MB; Gomez DE; Ripoll GV; Alonso DF
Clin Exp Metastasis; 2016 Aug; 33(6):589-600. PubMed ID: 27146156
[TBL] [Abstract][Full Text] [Related]
11. Antimetastatic effect of desmopressin in a mouse mammary tumor model.
Alonso DF; Skilton G; Farías EF; Bal de Kier Joffé E; Gomez DE
Breast Cancer Res Treat; 1999 Oct; 57(3):271-5. PubMed ID: 10617303
[TBL] [Abstract][Full Text] [Related]
12. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
13. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma.
Alonso DF; Farías EF; Urtreger A; Ladeda V; Vidal MC; Bal De Kier Joffé E
J Surg Oncol; 1996 Aug; 62(4):288-97. PubMed ID: 8691844
[TBL] [Abstract][Full Text] [Related]
14. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
[TBL] [Abstract][Full Text] [Related]
15. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
16. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Orsolić N; Basić I
Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
[TBL] [Abstract][Full Text] [Related]
17. The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.
Garona J; Pifano M; Orlando UD; Pastrian MB; Iannucci NB; Ortega HH; Podesta EJ; Gomez DE; Ripoll GV; Alonso DF
Int J Oncol; 2015; 46(6):2335-45. PubMed ID: 25846632
[TBL] [Abstract][Full Text] [Related]
18. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V
Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667
[TBL] [Abstract][Full Text] [Related]
19. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer.
Doi H; Shibata MA; Shibata E; Morimoto J; Akao Y; Iinuma M; Tanigawa N; Otsuki Y
Anticancer Res; 2009 Jul; 29(7):2485-95. PubMed ID: 19596918
[TBL] [Abstract][Full Text] [Related]
20. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.
Ripoll GV; Garona J; Pifano M; Farina HG; Gomez DE; Alonso DF
Breast Cancer Res Treat; 2013 Nov; 142(1):9-18. PubMed ID: 24122393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]